Dr. Robert C. Rennert, MD

Dr. Rennert practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Rennert's NPI, 1477966851, was assigned on June 3, 2014. Dr. Rennert graduated from Ohio State College of Medicine in 2014. Dr. Rennert's California license number on file is A139629.

Dr. Rennert's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Rennert's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Rennert is also affiliated with University of Utah Hospital. The medical group on file is Portneuf Medical Center - Pediatric Cardiology. Dmand AI also links Dr. Rennert to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rennert practices, 5 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Rennert's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dmand AI has Dr. Rennert's licenses on file in 7 states: California, Colorado, Idaho, Montana, Nevada, Utah and Wyoming.

Dmand AI lists craniotomy among the conditions Dr. Rennert treats.

CMS data shows 185 Medicare services from Dr. Rennert across 10 procedure codes in 2024, for 83 Medicare patients. Medicare paid $20,046 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 83 Medicare patients who saw Dr. Rennert in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have high blood pressure, and 64% have stroke or tia. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rennert's median patient age at 70, with 54% women.

In 2024, Dr. Rennert wrote 61 Medicare Part D claims for 16 patients. 79% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $4,215 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Rennert for performance year 2024, reported as part of a group. Dr. Rennert accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rennert as offering telehealth.

Dmand AI links 168 papers to Dr. Rennert, published from 2013 to 2025. 2022 was the busiest year, with 23. The most frequent topics are Neurosurgical Procedures, Brain Neoplasms and Wound Healing. Dr. Rennert has published most often in World Neurosurg. Dr. Rennert's most frequent co-authors are William Tupper Couldwell, MD, Alexander A. Khalessi, MD, MS and Jeffrey Alan Steinberg, MD.

CMS Open Payments shows 67 general payments to Dr. Rennert from 11 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 61% of the total. Medtronic, Inc. paid the most, $1,892.

Dr. Rennert graduated from Ohio State College of Medicine in 2014. Dr. Rennert is a member of CNS.

Dr. Rennert is in network with 19 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.